Anti-Human PD-1, rabbit IgG |
MBS432035-01mg |
MyBiosource |
0.1mg |
EUR 370 |
Human IgG antibody Laboratories manufactures the rat pd-1 elisa reagents distributed by Genprice. The Rat Pd-1 Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact rat elisa. Other Rat products are available in stock. Specificity: Rat Category: Pd-1 Group: Elisa
Human True insulin ELISA kit |
BlueGene |
96 wells plate |
EUR 405 |
Human True Insulin GENLISA ELISA |
Krishgen |
1 x 96 wells |
EUR 286 |
Human True Insulin ELISA Kit |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human True Insulin ELISA Kit |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human True Insulin ELISA Kit |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human True Insulin ELISA Kit |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human True insulin ELISA Kit |
MyBiosource |
48-Strip-Wells-(Competitive) |
EUR 485 |
Elisa information
PD-1 [Biotinylated] : PD-L1 Inhibitor Screening ELISA Kit |
EP-101-96tests |
ACROBIOSYSTEMS |
96tests |
EUR 664.9 |
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists. |
PD-1 [Biotinylated] : PD-L2 Inhibitor Screening ELISA Kit |
EP-120 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
Description: PD-L2, also known as CD273 or B7-DC, is a member of the B7 family protein with PD-L1, and it is the second important ligand that can bind pD-1 after PD-L1. The human PD-L2(B7-H2, CD273) gene is also located on chromosome 9p24, encoding type I transmembrane protein with 247 amino acids. The homology of PD-L1 and PD-L2 was 40%. The affinity between PD-L2 and PD-1 is 2-6 times that of PD-L1. Compared with PD-L1, the expression of PD-L2 is relatively limited, and pD-L2 is induced to express on the surface of dendritic cells, macrophages, bone marrow derived mast cells and other cells. |
PD-1 [Biotinylated] : PD-L2 Inhibitor Screening ELISA Kit |
EP-120-96tests |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
Description: PD-L2, also known as CD273 or B7-DC, is a member of the B7 family protein with PD-L1, and it is the second important ligand that can bind pD-1 after PD-L1. The human PD-L2(B7-H2, CD273) gene is also located on chromosome 9p24, encoding type I transmembrane protein with 247 amino acids. The homology of PD-L1 and PD-L2 was 40%. The affinity between PD-L2 and PD-1 is 2-6 times that of PD-L1. Compared with PD-L1, the expression of PD-L2 is relatively limited, and pD-L2 is induced to express on the surface of dendritic cells, macrophages, bone marrow derived mast cells and other cells. |
PD-1 : PD-L1 [Biotinylated] Inhibitor Screening ELISA Kit |
EP-130 |
ACROBIOSYSTEMS |
96tests |
EUR 664.9 |
|
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists. |
PD-1 : PD-L1 [Biotinylated] Inhibitor Screening ELISA Kit |
EP-130-96tests |
ACROBIOSYSTEMS |
96tests |
EUR 664.9 |
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists. |
PD-L1 : PD-1 [Biotinylated] Inhibitor Screening ELISA Kit |
EP-133 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists. |
PD-L1 : PD-1 [Biotinylated] Inhibitor Screening ELISA Kit |
EP-133-96tests |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists. |
PD-1 : PD-L2 [Biotinylated] Inhibitor Screening ELISA Kit |
EP-154 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists. |
PD-1 : PD-L2 [Biotinylated] Inhibitor Screening ELISA Kit |
EP-154-96tests |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists. |
PD-L1 [Biotinylated] : PD-1 Inhibitor Screening ELISA Kit |
EP-158 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists. |
PD-L1 [Biotinylated] : PD-1 Inhibitor Screening ELISA Kit |
EP-158-96tests |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
Description: Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists. |
Human PD-1/PDCD1 ELISA Kit |
MBS8123857-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2200 |
Human PD-1/PDCD1 ELISA Kit |
MBS8123857-96Tests |
MyBiosource |
96Tests |
EUR 480 |
Human PD-1 PicoKine ELISA Kit |
MBS177236-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2755 |